GLUE Insider Trading - Monte Rosa Therapeutics, Inc.

Deler fremragende	61,759,350 shares
Insideraktier	107.616.234 shares
Total Insiders	38

Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Se Højest rangerende aktier

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Se Højest rangerende aktier

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )

5615 out of 11308

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000 %( )

5561 out of 11226

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Monte Rosa Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider	Aktier Ejet	Dele Justeret
Forest Baskett 10% Owner - [10%]	7.692.298	7.692.298
Ali Behbahani Director, 10% Owner - [D] [10%]	7.692.298	7.692.298
Bradley J PhD Bolzon Director, 10% Owner - [D] [10%]	2.097.938	2.097.938
Castle John C. Chief Data Scientist - [O]	17.310	17.310
Jennifer Champoux Chief Operating Officer - [O]	30.000	30.000
Carmen Chang 10% Owner - [10%]	7.692.298	7.692.298
Bihua Chen Director, 10% Owner - [D] [10%]	3.202.200	3.202.200
Cormorant Asset Management, LLC -	3.202.200	3.202.200
Cormorant Global Healthcare Master Fund, LP 10% Owner - [10%]	3.202.200	3.202.200
Cormorant Private Healthcare Fund II, LP 10% Owner - [10%]	3.202.200	3.202.200
Cormorant Private Healthcare Fund III LP 10% Owner - [10%]	3.202.200	3.202.200
Edmund Dunn Principal Accounting Officer - [O]	23.732	23.732

Insider	Aktier Ejet	Dele Justeret
Florence Anthony A. Jr. 10% Owner - [10%]	7.692.298	7.692.298
Filip Janku Chief Medical Officer - [O]	45.189	45.189
Julian G Jones	73.300
Liza Landsman 10% Owner - [10%]	7.692.298	7.692.298
Leo Chandra P. Director - [D]	10.000	10.000
Joshua Makower 10% Owner - [10%]	7.692.298	7.692.298
Mohamad Makhzoumi 10% Owner - [10%]	7.692.298	7.692.298
Edward T Mathers 10% Owner - [10%]	7.692.298	7.692.298
Nea 17 Gp, Llc 10% Owner - [10%]	7.692.298	7.692.298
NEA Partners 17, L.P. 10% Owner - [10%]	7.692.298	7.692.298
New Enterprise Associates 17, L.P. 10% Owner - [10%]	7.692.298	7.692.298
Philip Nickson Chief Business & Legal Officer - [O]	36.000	36.000
Scott D Sandell 10% Owner - [10%]	7.692.298	7.692.298

Insider	Aktier Ejet	Dele Justeret
Sonsini Peter W. 10% Owner - [10%]	7.692.298	7.692.298
Ajim Tamboli	111.700
Sharon Townson Chief Scientific Officer - [O]	36.000	36.000
Versant Vantage I GP, L.P. 10% Owner - [10%]	2.097.938	1.573.453
Versant Vantage I GP-GP, LLC 10% Owner - [10%]	2.097.938	1.573.453
Versant Vantage I, L.P. 10% Owner - [10%]	2.097.938	1.573.453
Versant Venture Capital VI, L.P. 10% Owner - [10%]	1.573.453	1.573.453
Versant Ventures VI GP, L.P. 10% Owner - [10%]	2.097.938	1.573.453
Versant Ventures VI GP-GP, LLC 10% Owner - [10%]	2.097.938	1.573.453
Paul Edward Walker 10% Owner - [10%]	7.692.298	7.692.298
Wallace Owen B.	117.450
Markus Warmuth President & CEO, Director - [D] [O]	544.538	544.538
Rick Yang 10% Owner - [10%]	7.692.298	7.692.298

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i GLUE / Monte Rosa Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Maks	Pris kl Maks	Maks Fortjeneste ($)	Maks. afkast (%)
2025-03-24	Leo Chandra P.	10.000	5,8383	10.000	5,8383	58.383	121	5.9600	1.217	2,08
2021-06-28	Cormorant Asset Management, LLC	600.000	19,0000	600.000	19,0000	11.400.000
2021-06-28	Versant Venture Capital VI, L.P.	157.895	19,0000	157.895	19,0000	3.000.005
2021-06-28	Bolzon Bradley J PhD	157.895	19,0000	157.895	19,0000	3.000.005
2021-06-28	New Enterprise Associates 17, L.P.	1.050.000	19,0000	1.050.000	19,0000	19.950.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GLUE / Monte Rosa Therapeutics, Inc. Insider Trades

Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i GLUE / Monte Rosa Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato	Insider	Rapporteret Aktier	Rapporteret Pris	Justeret Aktier	Justeret Pris	Omkostningsgrundlag	dage til Min	Pris kl Min	Max tab Undgået ($)	Max tab Undgået (%)
2025-06-03	Dunn Edmund	2.062	4,4493	2.062	4,4493	9.174	69	4.1900	-534	-5,82
2024-10-29	Versant Venture Capital VI, L.P.	15.600	9,4098	15.600	9,4098	146.793
2024-10-29	Versant Venture Capital VI, L.P.	52.305	9,0815	52.305	9,0815	475.008
2024-10-28	Versant Venture Capital VI, L.P.	89.990	9,6593	89.990	9,6593	869.240
2024-09-20	Versant Venture Capital VI, L.P.	1.132.566	6,5296	1.132.566	6,5296	7.395.203
2024-09-13	Versant Venture Capital VI, L.P.	9.269	6,1603	9.269	6,1603	57.100
2024-09-12	Versant Venture Capital VI, L.P.	16.047	6,0017	16.047	6,0017	96.309
2024-09-11	Versant Venture Capital VI, L.P.	541.897	6,0000	541.897	6,0000	3.251.382
2024-07-05	Dunn Edmund	1.610	3,8301	1.610	3,8301	6.166
2024-06-03	Dunn Edmund	1.207	4,0396	1.207	4,0396	4.876

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil Dato	Handle Dato	Form	Insider	Ticker	Sikkerhedstitel	Kode	Direkte	Dyrke motion Pris	Enhed Pris	Enheder Ændret	Værdi Ændret (1K)	Tilbage Muligheder	Tilbage Aktier
2025-06-04	2025-06-03	4	Dunn Edmund	GLUE	Common Stock	S - Sale	D		4,4493	-2.062	-9		23.732
2025-03-25	2025-03-24	4	Leo Chandra P.	GLUE	Common Stock	P - Purchase	D		5,8383	10.000	58		10.000
2025-01-06	2025-01-02	4	Warmuth Markus	GLUE	Common Stock	A - Award	D			128.000			544.538
2025-01-06	2025-01-02	4	Janku Filip	GLUE	Common Stock	A - Award	D			36.000			45.189
2025-01-06	2025-01-02	4	Townson Sharon	GLUE	Common Stock	A - Award	D			36.000			36.000
2025-01-06	2025-01-02	4	Champoux Jennifer	GLUE	Common Stock	A - Award	D			30.000			30.000
2025-01-06	2025-01-02	4	Dunn Edmund	GLUE	Common Stock	A - Award	D			11.850			25.794
2025-01-06	2025-01-02	4	Nickson Philip	GLUE	Common Stock	A - Award	D			36.000			36.000
2024-10-30	2024-10-29	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	S - Sale	I		9,4098	-15.600	-147		1.573.453
2024-10-30	2024-10-29	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	S - Sale	I		9,0815	-52.305	-475		1.589.053
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			-5.454			0
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			5.454			5.454
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			-5.499			0
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			5.499			5.499
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			-366.590			1.641.358
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			-17.595			0
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			17.595			17.595
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			-20.397			0
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	I			20.397			20.397
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	J - Other	D			-1.019.867			4.079.469
2024-10-30	2024-10-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	S - Sale	I		9,6593	-89.990	-869		2.007.948
2024-09-24	2024-09-20	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	S - Sale	D		6,5296	-1.132.566	-7.395		5.099.336
2024-09-13	2024-09-13	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	S - Sale	D		6,1603	-9.269	-57		6.231.902
2024-09-13	2024-09-12	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	S - Sale	D		6,0017	-16.047	-96		6.241.171
2024-09-13	2024-09-11	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	S - Sale	D		6,0000	-541.897	-3.251		6.257.218
2024-07-09	2024-07-05	4	Dunn Edmund	GLUE	Common Stock	S - Sale	D		3,8301	-1.610	-6		13.944
2024-06-05	2024-06-03	4	Dunn Edmund	GLUE	Common Stock	S - Sale	D		4,0396	-1.207	-5		15.554
2023-08-18		3	Dunn Edmund	GLUE	Common Stock		D						16.761
2022-03-02	2022-03-01	4	Jones Julian G	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		73.300		73.300
2022-03-02	2022-03-01	4	Janku Filip	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		86.500		86.500
2022-03-02	2022-03-01	4	Tamboli Ajim	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		111.700		111.700
2022-03-02	2022-03-01	4	Townson Sharon	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		70.000		70.000
2022-03-02	2022-03-01	4	Nickson Philip	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		70.600		70.600
2022-03-02	2022-03-01	4	Castle John C.	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		53.700		53.700
2022-03-02	2022-03-01	4	Wallace Owen B.	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		117.450		117.450
2022-03-02	2022-03-01	4	Warmuth Markus	GLUE	Stock Option (Right to Buy)	A - Award	D	13,41		315.600		315.600
2021-06-30	2021-06-28	4	Yang Rick See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Yang Rick See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Yang Rick See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Yang Rick See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Yang Rick See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Yang Rick See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Yang Rick See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Sonsini Peter W. See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Sonsini Peter W. See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Sonsini Peter W. See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Sonsini Peter W. See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Sonsini Peter W. See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Sonsini Peter W. See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Sonsini Peter W. See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Walker Paul Edward See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Walker Paul Edward See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Walker Paul Edward See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Walker Paul Edward See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Walker Paul Edward See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Walker Paul Edward See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Walker Paul Edward See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	SANDELL SCOTT D See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	SANDELL SCOTT D See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	SANDELL SCOTT D See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	SANDELL SCOTT D See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	SANDELL SCOTT D See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	SANDELL SCOTT D See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	SANDELL SCOTT D See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Mathers Edward T See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Mathers Edward T See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Mathers Edward T See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Mathers Edward T See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Mathers Edward T See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Mathers Edward T See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Mathers Edward T See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	MAKOWER JOSHUA See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	MAKOWER JOSHUA See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	MAKOWER JOSHUA See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	MAKOWER JOSHUA See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	MAKOWER JOSHUA See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	MAKOWER JOSHUA See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	MAKOWER JOSHUA See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Makhzoumi Mohamad See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Makhzoumi Mohamad See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Makhzoumi Mohamad See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Makhzoumi Mohamad See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Makhzoumi Mohamad See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Makhzoumi Mohamad See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Makhzoumi Mohamad See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Landsman Liza See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Landsman Liza See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Landsman Liza See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Landsman Liza See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Landsman Liza See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Landsman Liza See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Landsman Liza See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Chang Carmen See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Chang Carmen See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Chang Carmen See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Chang Carmen See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Chang Carmen See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Chang Carmen See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Chang Carmen See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Florence Anthony A. Jr. See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Florence Anthony A. Jr. See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Florence Anthony A. Jr. See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Florence Anthony A. Jr. See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Florence Anthony A. Jr. See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Florence Anthony A. Jr. See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Florence Anthony A. Jr. See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	BASKETT FOREST See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	BASKETT FOREST See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	BASKETT FOREST See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	BASKETT FOREST See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	BASKETT FOREST See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	BASKETT FOREST See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	BASKETT FOREST See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Behbahani Ali See Note 2	GLUE	Series C convertible preferred Stock	C - Conversion	I			-2.361.912		0
2021-06-30	2021-06-28	4	Behbahani Ali See Note 2	GLUE	Series B convertible preferred stock	C - Conversion	I			-11.500.000		0
2021-06-30	2021-06-28	4	Behbahani Ali See Note 2	GLUE	Series A-2 convertible preferred stock	C - Conversion	I			-9.588.725		0
2021-06-30	2021-06-28	4	Behbahani Ali See Note 2	GLUE	Common Stock	P - Purchase	I		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	Behbahani Ali See Note 2	GLUE	Common Stock	C - Conversion	I			669.002			6.642.298
2021-06-30	2021-06-28	4	Behbahani Ali See Note 2	GLUE	Common Stock	C - Conversion	I			3.257.328			5.973.296
2021-06-30	2021-06-28	4	Behbahani Ali See Note 2	GLUE	Common Stock	C - Conversion	I			2.715.968			2.715.968
2021-06-30	2021-06-28	4	New Enterprise Associates 17, L.P.	GLUE	Series C convertible preferred Stock	C - Conversion	D			-2.361.912		0
2021-06-30	2021-06-28	4	New Enterprise Associates 17, L.P.	GLUE	Series B convertible preferred stock	C - Conversion	D			-11.500.000		0
2021-06-30	2021-06-28	4	New Enterprise Associates 17, L.P.	GLUE	Series A-2 convertible preferred stock	C - Conversion	D			-9.588.725		0
2021-06-30	2021-06-28	4	New Enterprise Associates 17, L.P.	GLUE	Common Stock	P - Purchase	D		19,0000	1.050.000	19.950		7.692.298
2021-06-30	2021-06-28	4	New Enterprise Associates 17, L.P.	GLUE	Common Stock	C - Conversion	D			669.002			6.642.298
2021-06-30	2021-06-28	4	New Enterprise Associates 17, L.P.	GLUE	Common Stock	C - Conversion	D			3.257.328			5.973.296
2021-06-30	2021-06-28	4	New Enterprise Associates 17, L.P.	GLUE	Common Stock	C - Conversion	D			2.715.968			2.715.968
2021-06-30	2021-06-28	4	Bolzon Bradley J PhD By Versant Vantage I, L.P.	GLUE	Series C convertible preferred stock	C - Conversion	I			-2.699.328		0
2021-06-30	2021-06-28	4	Bolzon Bradley J PhD By Versant Vantage I, L.P.	GLUE	Series B convertible preferred stock	C - Conversion	I			-4.150.000		0
2021-06-30	2021-06-28	4	Bolzon Bradley J PhD By Versant Capital VI, L.P.	GLUE	Series B convertible preferred stock	C - Conversion	I			-3.000.000		0
2021-06-30	2021-06-28	4	Bolzon Bradley J PhD By Versant Capital VI, L.P.	GLUE	Series A convertible preferred stock	C - Conversion	I			-20.004.280		0
2021-06-30	2021-06-28	4	Bolzon Bradley J PhD By Versant Vantage I, L.P.	GLUE	Common Stock	P - Purchase	I		19,0000	157.895	3.000		2.097.938
2021-06-30	2021-06-28	4	Bolzon Bradley J PhD By Versant Vantage I, L.P.	GLUE	Common Stock	C - Conversion	I			1.940.043			1.940.043
2021-06-30	2021-06-28	4	Bolzon Bradley J PhD By Versant Venture Capital VI, L.P.	GLUE	Common Stock	C - Conversion	I			6.515.869			6.799.115
2021-06-30	2021-06-28	4	Versant Venture Capital VI, L.P. By Versant Vantage I, L.P.	GLUE	Series C convertible preferred stock	C - Conversion	I			-2.699.328		0
2021-06-30	2021-06-28	4	Versant Venture Capital VI, L.P. By Versant Vantage I, L.P.	GLUE	Series B convertible preferred stock	C - Conversion	I			-4.150.000		0
2021-06-30	2021-06-28	4	Versant Venture Capital VI, L.P.	GLUE	Series B convertible preferred stock	C - Conversion	D			-3.000.000		0
2021-06-30	2021-06-28	4	Versant Venture Capital VI, L.P.	GLUE	Series A convertible preferred stock	C - Conversion	D			-20.004.280		0
2021-06-30	2021-06-28	4	Versant Venture Capital VI, L.P. By Versant Vantage I, L.P.	GLUE	Common Stock	P - Purchase	I		19,0000	157.895	3.000		2.097.938
2021-06-30	2021-06-28	4	Versant Venture Capital VI, L.P. By Versant Vantage I, L.P.	GLUE	Common Stock	C - Conversion	I			1.940.043			1.940.043
2021-06-30	2021-06-28	4	Versant Venture Capital VI, L.P.	GLUE	Common Stock	C - Conversion	D			6.515.869			6.799.115
2021-06-30	2021-06-28	4	Cormorant Asset Management, LLC See Footnotes	GLUE	Series C Convertible Preferred Stock	C - Conversion	I			477.857		0
2021-06-30	2021-06-28	4	Cormorant Asset Management, LLC See Footnotes	GLUE	Series B Convertible Preferred Stock	C - Conversion	I			2.124.343		0
2021-06-30	2021-06-28	4	Cormorant Asset Management, LLC See Footnotes	GLUE	Common Stock	P - Purchase	I		19,0000	600.000	11.400		3.202.200
2021-06-30	2021-06-28	4	Cormorant Asset Management, LLC See Footnotes	GLUE	Common Stock	C - Conversion	I			2.602.200			2.602.200
2021-06-25	2021-06-23	4	Behbahani Ali	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		47.132		47.132
2021-06-25	2021-06-23	4	Blackwell Kimberly	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		47.132		47.132
2021-06-25	2021-04-12	4	Blackwell Kimberly	GLUE	Stock Option (Right to Buy)	A - Award	D	6,14		7.081		7.081
2021-06-25	2021-06-23	4	Janku Filip	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		387.069		387.069
2021-06-25	2021-06-23	4	Mayweg Alexander	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		47.132		47.132
2021-06-25	2021-06-23	4	SCHIFF ANDREW N	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		47.132		47.132
2021-06-25	2021-06-23	4	Bolzon Bradley J PhD	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		47.132		47.132
2021-06-25	2021-03-11	4	Bolzon Bradley J PhD By Versant Vantage I, L.P.	GLUE	Series C convertible preferred stock	A - Award	I		2,9637	2.699.328	8.000	2.699.328
2021-06-25	2021-02-24	4	Bolzon Bradley J PhD By Versant Vantage I, L.P.	GLUE	Series B convertible preferred stock	A - Award	I		2,0000	2.075.000	4.150	4.150.000
2021-06-25	2021-02-24	4	Bolzon Bradley J PhD By Versant Capital VI, L.P.	GLUE	Series B convertible preferred stock	A - Award	I		2,0000	1.500.000	3.000	3.000.000
2021-06-25	2021-06-23	4	Warmuth Markus	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		141.623		141.623
2021-06-25	2021-04-12	4	Warmuth Markus	GLUE	Stock Option (Right to Buy)	A - Award	D	6,14		538.517		538.517
2021-06-25	2021-06-23	4	Wallace Owen B.	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		113.298		113.298
2021-06-25	2021-04-12	4	Wallace Owen B.	GLUE	Stock Option (Right to Buy)	A - Award	D	6,14		387.069		387.069
2021-06-25	2021-06-23	4	Siu Christine	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		47.132		47.132
2021-06-25	2021-04-12	4	Siu Christine	GLUE	Stock Option (Right to Buy)	A - Award	D	6,14		7.081		7.081
2021-06-25	2021-06-23	4	Leo Chandra P.	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		47.132		47.132
2021-06-25	2021-06-23	4	Tamboli Ajim	GLUE	Stock Option (Right to Buy)	A - Award	D	19,00		56.649		56.649
2021-06-25	2021-04-12	4	Tamboli Ajim	GLUE	Stock Option (Right to Buy)	A - Award	D	6,14		100.938		100.938
2021-06-23		3	Bolzon Bradley J PhD By Versant Venture Capital VI, L.P.	GLUE	Common Stock		I						283.246
2021-06-23		3	Castle John C.	GLUE	Common Stock		D						17.310
2021-06-23		3	Warmuth Markus	GLUE	Common Stock		D						416.538
2021-06-23		3	Versant Vantage I GP-GP, LLC	GLUE	Common Stock		D						283.246

Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer

Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer

Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)

Konvertering af derivat

Salg eller overførsel af værdipapirer tilbage til virksomheden

Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet

Gave af værdipapirer af eller til insideren

Aktieswaps og lignende sikringstransaktioner

Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)

En transaktion rapporteret frivilligt på formular 4

Andet (ledsaget af en fodnote, der beskriver transaktionen)

GLUE / Monte Rosa Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5